Muscarinic M1, M3, Nicotinic,GABAA and GABAB Receptor ...

Boess FG, De Vry J, Erb C, Flessner T, Hendrix M, Luithle J, Methfessel C, Riedl B,
Schnizler K, van der Staay FJ, van Kampen M, Wiese WB, Koenig G. (2007).
The novel alpha7 nicotinic acetylcholine receptor agonist N– [(3R)–1–
azabicyclo[2.2.2]oct–3–yl]–7–[2–(methoxy)phenyl]–1–benzofuran–2–arboxamide
improves working and recognition memory in rodents. J. Pharmacol. Exp. Ther,
321: 716–725.
Bond RW, Wyborski RJ, Gottlieb DI. (1990). Developmentally regulated expression
of an exon containing a stop codon in the gene for glutamic acid decarboxylase.
Proc Natl Acad Sci U S A, 87: 8771–8775 Szabo G, Katarova Z, Greenspan R.
(1994). Distinct protein forms are produced from alternatively spliced bicistronic
glutamic acid decarboxylase mRNAs during development. Mol Cell Biol, 14:
7535–7545.
Bonner–Weir S, Deery D, Leahy JL, Weir GC. (1989). Compensatory growth of
pancreatic beta–cells in adult rats after short– term glucose infusion. Diabetes, 38:
49–53.
Bormann J. (2000). The 'ABC' of GABA receptors. Trends Pharmacol Sci, 21: 16–19.
Bosch D, Schmid S. (2008). Cholinergic mechanism underlying prepulse inhibition of
the startle response in rats. Neuroscience, 155: 326–35.
Botez–Marquard TC, Bard J, Leveille MI, Botez. (2001). A severe frontal–parietal
lobe syndrome following cerebellar damage. Eur J of Neurol, 8: 347–353.
Bouilleret V, Semah F, Biraben A, Taussig D, Chassoux F, Syrota A, Ribeiro MJ.
(2005). Involvement of the basal ganglia in refractory epilepsy: an 18F–fluoro–L–
DOPA PET study using 2 methods of analysis. J Nucl Med, 46: 540–547.